The advancements in technology and medicines have constantly increased our life expectancy over the past century and together with the baby boomer generation is leading to a significant demographic change of the society. As a result the population older that 65 years is predicted to reach 25 % of the total population in the Western world within the next decades including a significant shift towards the population of 85 years plus. With age the incidence for chronic diseases increases and functional capabilities start gradually to decline; however these phenomena is independent from the numerical age and happen in a very individual manners. Older people therefore are the most heterogenic population.

Drug therapy remains the major invention to cure or manage acute and chronic diseases. With the number of available drugs/drug classes and the access to several physicians from different disciplines independently, drug therapy can become a very complex interplay of physician’s diagnosis, patient constitutions & capabilities and drug & drug product characteristics. As a result, drug therapy related adverse drug events and therapeutic complications can occur which in worst case could cause complications which are to be treated in emergency rooms and/or hospitals. The reasons for the high incident of therapeutic complications in the geriatric patient population is caused by a variety of factors like the aging process of the individual, the increasing number of therapeutic interventions as well as the provision of healthcare within the healthcare systems.

The healthcare provision to geriatric patients of which drug therapy is an important part includes a variety of direct and indirect stakeholders including relatives and media. Geriatric drug therapy is a challenge of all the stakeholders involved and as such a society challenge. The direct stakeholders like physicians, pharmacists, care givers, etc as well as the indirect stakeholders like the pharmaceutical industry, regulatory bodies, healthcare insurance companies, etc and most important the patients themselves need to be involved in the process towards better therapeutic care of geriatric patients.

Improving the outcomes of geriatric therapy requires a multidisciplinary and holistic review of the various known and unknown healthcare issues that an aging individual is facing, important interdisciplinary research into geriatric drug therapy with the objective to identify, develop and proof better and more efficient way of drug therapy to the aging population.

Webdesign by Tostaky